Maria Zannes
President, CEO at bioAffinity Technologies Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: bioAffinity Technologies Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
bioAffinity Technologies Inc. July 25, 202598.5%
-
bioAffinity Technologies Inc. June 4, 202499.6%
-
bioAffinity Technologies Inc. June 7, 202399.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 10, 2025 | bioAffinity Technologies Inc. | Grant or award | +37,037 | — | — |
| Jul 1, 2024 | bioAffinity Technologies Inc. | Grant or award | +33,784 | — | — |
| Jun 12, 2024 | bioAffinity Technologies Inc. | Grant or award | +8,296 | — | — |
| Apr 8, 2024 | bioAffinity Technologies Inc. | Option exercise | +64,848 | $1.16 | $75,224 |
| Apr 8, 2024 | bioAffinity Technologies Inc. | Shares withheld for tax | −28,264 | $2.65 | $74,900 |
| Jan 31, 2024 | bioAffinity Technologies Inc. | Grant or award | +23,885 | — | — |
| Jan 1, 2024 | bioAffinity Technologies Inc. | Grant or award | +12,668 | $1.48 | $18,749 |
| Oct 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +11,867 | $1.58 | $18,750 |
| Jul 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +10,245 | $1.83 | $18,748 |
| Jun 6, 2023 | bioAffinity Technologies Inc. | Grant or award | +26,178 | $1.91 | $50,000 |
| Apr 15, 2023 | bioAffinity Technologies Inc. | Grant or award | +9,920 | $1.89 | $18,749 |
| Jan 1, 2023 | bioAffinity Technologies Inc. | Grant or award | +8,227 | $2.28 | $18,758 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.